These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22294672)

  • 1. On the covariate-adjusted estimation for an overall treatment difference with data from a randomized comparative clinical trial.
    Tian L; Cai T; Zhao L; Wei LJ
    Biostatistics; 2012 Apr; 13(2):256-73. PubMed ID: 22294672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expected estimating equations via EM for proportional hazards regression with covariate misclassification.
    Wang CY; Song X
    Biostatistics; 2013 Apr; 14(2):351-65. PubMed ID: 23178735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian variable selection method for censored survival data.
    Faraggi D; Simon R
    Biometrics; 1998 Dec; 54(4):1475-85. PubMed ID: 9883546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction trees with censored survival data.
    Su X; Zhou T; Yan X; Fan J; Yang S
    Int J Biostat; 2008 Jan; 4(1):Article 2. PubMed ID: 20231911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjusting for observational secondary treatments in estimating the effects of randomized treatments.
    Zhang M; Wang Y
    Biostatistics; 2013 Jul; 14(3):491-501. PubMed ID: 23349243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moving beyond the conventional stratified analysis to estimate an overall treatment efficacy with the data from a comparative randomized clinical study.
    Tian L; Jiang F; Hasegawa T; Uno H; Pfeffer M; Wei LJ
    Stat Med; 2019 Mar; 38(6):917-932. PubMed ID: 30352486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Robust Alternatives to ANCOVA for Estimating the Treatment Effect via a Randomized Comparative Study.
    Jiang F; Tian L; Fu H; Hasegawa T; Wei LJ
    J Am Stat Assoc; 2019; 114(528):1854-1864. PubMed ID: 37982094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variable selection for covariate-adjusted semiparametric inference in randomized clinical trials.
    Yuan S; Zhang HH; Davidian M
    Stat Med; 2012 Dec; 31(29):3789-804. PubMed ID: 22733628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inverse probability weighting for covariate adjustment in randomized studies.
    Shen C; Li X; Li L
    Stat Med; 2014 Feb; 33(4):555-68. PubMed ID: 24038458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjusted Kaplan-Meier estimator and log-rank test with inverse probability of treatment weighting for survival data.
    Xie J; Liu C
    Stat Med; 2005 Oct; 24(20):3089-110. PubMed ID: 16189810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Irwin's restricted mean as an index for comparing survival in different treatment groups--interpretation and power considerations.
    Karrison TG
    Control Clin Trials; 1997 Apr; 18(2):151-67. PubMed ID: 9129859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Empirical efficiency maximization: improved locally efficient covariate adjustment in randomized experiments and survival analysis.
    Rubin DB; van der Laan MJ
    Int J Biostat; 2008; 4(1):Article 5. PubMed ID: 19381345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restricted mean survival time: Does covariate adjustment improve precision in randomized clinical trials?
    Karrison T; Kocherginsky M
    Clin Trials; 2018 Apr; 15(2):178-188. PubMed ID: 29502444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conditional estimation and inference to address observed covariate imbalance in randomized clinical trials.
    Zhang Z; Tang L; Liu C; Berger VW
    Clin Trials; 2019 Apr; 16(2):122-131. PubMed ID: 30444129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving efficiency of inferences in randomized clinical trials using auxiliary covariates.
    Zhang M; Tsiatis AA; Davidian M
    Biometrics; 2008 Sep; 64(3):707-715. PubMed ID: 18190618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of covariance in randomized trials: More precision and valid confidence intervals, without model assumptions.
    Wang B; Ogburn EL; Rosenblum M
    Biometrics; 2019 Dec; 75(4):1391-1400. PubMed ID: 31009064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjusting for bias introduced by instrumental variable estimation in the Cox proportional hazards model.
    Martínez-Camblor P; Mackenzie T; Staiger DO; Goodney PP; O'Malley AJ
    Biostatistics; 2019 Jan; 20(1):80-96. PubMed ID: 29267847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Censored quantile regression with recursive partitioning-based weights.
    Wey A; Wang L; Rudser K
    Biostatistics; 2014 Jan; 15(1):170-81. PubMed ID: 23975800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Model misspecification and robustness in causal inference: comparing matching with doubly robust estimation.
    Waernbaum I
    Stat Med; 2012 Jul; 31(15):1572-81. PubMed ID: 22359267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlling ecological bias in evidence synthesis of trials reporting on collapsed and overlapping covariate categories.
    Govan L; Ades AE; Weir CJ; Welton NJ; Langhorne P
    Stat Med; 2010 May; 29(12):1340-56. PubMed ID: 20191599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.